Literature DB >> 9775698

Depression in Parkinson's disease. The impact of symptom overlap on prevalence.

W J Hoogendijk1, I E Sommer, G Tissingh, D J Deeg, E C Wolters.   

Abstract

The reported prevalence of depression concomitant with Parkinson's disease varies greatly in the literature, which may partly be explained by symptom overlap. To determine the impact of symptom overlap on the prevalence, the authors tested 100 Parkinson's disease patients for major depression (DSM-III-R) with both a standard, inclusive method and a diagnostic-etiologic, exclusive method. The authors found that the prevalence detected with the inclusive method (23%) decreased when the exclusive method was used (13%), which was mainly caused by lower scores on the item "loss of interest." The study's findings give empirical support for the relevance of the new category in DSM-IV "mood disorder due to a general medical condition."

Entities:  

Mesh:

Year:  1998        PMID: 9775698     DOI: 10.1016/S0033-3182(98)71300-3

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  14 in total

1.  Depression rating scales in Parkinson's disease: critique and recommendations.

Authors:  Anette Schrag; Paolo Barone; Richard G Brown; Albert F G Leentjens; William M McDonald; Sergio Starkstein; Daniel Weintraub; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

2.  Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia.

Authors:  Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Katia Longo; Autilia Cozzolino; Dario Grossi; Paolo Barone
Journal:  J Neurol       Date:  2009-04-15       Impact factor: 4.849

3.  Assessing depression and factors possibly associated with depression during the course of Parkinson's disease.

Authors:  Amy H Farabaugh; Joseph J Locascio; Liang Yap; Maurizio Fava; Stella Bitran; Jessica L Sousa; John H Growdon
Journal:  Ann Clin Psychiatry       Date:  2011-08       Impact factor: 1.567

Review 4.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

Review 5.  Antidepressant studies in Parkinson's disease: a review and meta-analysis.

Authors:  Daniel Weintraub; Knashawn H Morales; Paul J Moberg; Warren B Bilker; Catherine Balderston; John E Duda; Ira R Katz; Matthew B Stern
Journal:  Mov Disord       Date:  2005-09       Impact factor: 10.338

6.  Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilization.

Authors:  Peijun Chen; Helen C Kales; Daniel Weintraub; Frederic C Blow; Lan Jiang; Rosalinda V Ignacio; Alan M Mellow
Journal:  Int J Geriatr Psychiatry       Date:  2007-06       Impact factor: 3.485

7.  Depressive symptom patterns and their consequences for diagnosis of affective disorders in cancer patients.

Authors:  Katrin Reuter; Simone Raugust; Jürgen Bengel; Martin Härter
Journal:  Support Care Cancer       Date:  2004-10-09       Impact factor: 3.603

8.  Suicidal and death ideation in Parkinson's disease.

Authors:  Sarra Nazem; Andrew D Siderowf; John E Duda; Gregory K Brown; Tom Ten Have; Matthew B Stern; Daniel Weintraub
Journal:  Mov Disord       Date:  2008-08-15       Impact factor: 10.338

9.  Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease.

Authors:  Daniel Weintraub; Katherine A Oehlberg; Ira R Katz; Matthew B Stern
Journal:  Am J Geriatr Psychiatry       Date:  2006-02       Impact factor: 4.105

10.  Conceptualization of depression in Parkinson's disease.

Authors:  Jeffrey C Looi; May Matis; Michelle J Ruzich
Journal:  Neuropsychiatr Dis Treat       Date:  2005-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.